ArticleF1000Research2016

Validation of commercially available sphingosine kinase 2 antibodies for use in immunoblotting, immunoprecipitation and immunofluorescence.

Heidi A Neubauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.